Clarus Wealth Advisors Gsk PLC Transaction History

Clarus Wealth Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 11, 2019	SELL	$40.46 - $43.52 $25,611 - $27,548	-633 Closed	0 $0
Q2 2019 Jul 24, 2019	BUY	$39.4 - $42.7 $354 - $384	9 Added 1.44%	633 $25,000
Q1 2019 Apr 04, 2019	BUY	$38.57 - $42.69 $308 - $341	8 Added 1.3%	624 $26,000
Q4 2018 Feb 05, 2019	BUY	$37.8 - $42.69 $18,937 - $21,387	501 Added 435.65%	616 $24,000
Q4 2018 Jan 08, 2019	BUY	$37.8 - $42.69 $4,347 - $4,909	115 New	115 $5,000
Q4 2018 Jan 07, 2019	SELL	$37.8 - $42.69 $4,347 - $4,909	-115 Closed	0 $0
Q3 2018 Oct 03, 2018	BUY	$39.75 - $42.69 $119 - $128	3 Added 2.68%	115 $5,000
Q2 2018 Jul 05, 2018	BUY	$39.61 - $42.76 $4,436 - $4,789	112 New	112 $4,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Clarus Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Clarus Wealth Advisors with notifications on news.